Company · CIK 0001815442 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Kymera Therapeutics, Inc. · KYMR
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2026 SForm 4 → | Sep 4, 6:00 pm EDT | Brian AdamsChief Legal Officer | 6,371 | $116.83 | $744,297 | 50,254 | −11.3% |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.